Agonists induce conformational changes in transmembrane domains III and VI of the β2 adrenoceptor
暂无分享,去创建一个
H Weinstein | P Ghanouni | J. Ballesteros | H. Weinstein | B. Kobilka | P. Ghanouni | U. Gether | U Gether | B K Kobilka | J A Ballesteros | S Lin | S. Lin | Sansan Lin | Harel A. Weinstein | Ulrik Gether | Harel Weinstein
[1] A. Scheer,et al. The activation process of the alpha1B-adrenergic receptor: potential role of protonation and hydrophobicity of a highly conserved aspartate. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[2] Brian K. Kobilka,et al. Structural Instability of a Constitutively Active G Protein-coupled Receptor , 1997, The Journal of Biological Chemistry.
[3] H. Khorana,et al. Requirement of Rigid-Body Motion of Transmembrane Helices for Light Activation of Rhodopsin , 1996, Science.
[4] T. Schwartz,et al. Connectivity and orientation of the seven helical bundle in the tachykinin NK‐1 receptor probed by zinc site engineering. , 1996, The EMBO journal.
[5] O. Lichtarge,et al. Rhodopsin activation blocked by metal-ion-binding sites linking transmembrane helices C and F , 1996, Nature.
[6] H. Khorana,et al. Structural features and light-dependent changes in the cytoplasmic interhelical E-F loop region of rhodopsin: a site-directed spin-labeling study. , 1996, Biochemistry.
[7] A. IJzerman,et al. Involvement of Asn-293 in stereospecific agonist recognition and in activation of the beta 2-adrenergic receptor. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[8] Manuel Peitsch,et al. Probing the Structure and Function of the Tachykinin Neurokinin-2 Receptor through Biosynthetic Incorporation of Fluorescent Amino Acids at Specific Sites* , 1996, The Journal of Biological Chemistry.
[9] A. Scheer,et al. Constitutively active mutants of the alpha 1B‐adrenergic receptor: role of highly conserved polar amino acids in receptor activation. , 1996, The EMBO journal.
[10] Ying Sun,et al. The β-Chemokine Receptors CCR3 and CCR5 Facilitate Infection by Primary HIV-1 Isolates , 1996, Cell.
[11] Paul E. Kennedy,et al. HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor , 1996, Science.
[12] M. Maze,et al. Arrangement of Transmembrane Domains in Adrenergic Receptors , 1996, The Journal of Biological Chemistry.
[13] Kenneth A Jacobson,et al. Molecular architecture of G protein‐coupled receptors , 1996, Drug development research.
[14] H. Weinstein,et al. Conformational Memories and the Exploration of Biologically Relevant Peptide Conformations: An Illustration for the Gonadotropin-Releasing Hormone , 1996 .
[15] A. Strosberg,et al. Carazolol: a potent, selective β3-adrenoceptor agonist , 1995 .
[16] B. Kobilka,et al. Fluorescent labeling of purified beta 2 adrenergic receptor. Evidence for ligand-specific conformational changes. , 1995, The Journal of biological chemistry.
[17] M. Menziani,et al. Molecular dynamics simulations of m3-muscarinic receptor activation and QSAR analysis. , 1995, Bioorganic & medicinal chemistry.
[18] B. Kobilka. Amino and carboxyl terminal modifications to facilitate the production and purification of a G protein-coupled receptor. , 1995, Analytical biochemistry.
[19] J. Wess,et al. Mutational Analysis of the Relative Orientation of Transmembrane Helices I and VII in G Protein-coupled Receptors (*) , 1995, The Journal of Biological Chemistry.
[20] H. Khorana,et al. Mapping light-dependent structural changes in the cytoplasmic loop connecting helices C and D in rhodopsin: a site-directed spin labeling study. , 1995, Biochemistry.
[21] Frank Guarnieri,et al. Conformational memories and a simulated annealing program that learns: Application to LTB4 , 1995, J. Comput. Chem..
[22] Jonathan A Javitch,et al. Mapping the binding-site crevice of the dopamine D2 receptor by the substituted-cysteine accessibility method , 1995, Neuron.
[23] B. Roth,et al. Differential ergoline and ergopeptine binding to 5-hydroxytryptamine2A receptors: ergolines require an aromatic residue at position 340 for high affinity binding. , 1995, Molecular pharmacology.
[24] J. Ballesteros,et al. [19] Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors , 1995 .
[25] H. Weinstein,et al. Ligand-induced domain motion in the activation mechanism of a G-protein-coupled receptor. , 1994, Protein engineering.
[26] K. Fahmy,et al. A conserved carboxylic acid group mediates light-dependent proton uptake and signaling by rhodopsin. , 1994, The Journal of biological chemistry.
[27] T. Schwartz,et al. Locating ligand-binding sites in 7TM receptors by protein engineering. , 1994, Current opinion in biotechnology.
[28] E. Jacoby,et al. Modeling of G-protein coupled receptors with bacteriorhodopsin as a template. A novel approach based on interaction energy differences. , 1994, Journal of receptor research.
[29] R. Graham,et al. The high affinity state of the beta 2-adrenergic receptor requires unique interaction between conserved and non-conserved extracellular loop cysteines. , 1994, The Journal of biological chemistry.
[30] K Konvicka,et al. A reciprocal mutation supports helix 2 and helix 7 proximity in the gonadotropin-releasing hormone receptor. , 1994, Molecular pharmacology.
[31] C. Strader,et al. Structure and function of G protein-coupled receptors. , 1994, Annual review of biochemistry.
[32] R. Lefkowitz,et al. Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins. , 1993, Trends in pharmacological sciences.
[33] Gebhard F. X. Schertler,et al. Projection structure of rhodopsin , 1993, Nature.
[34] H Weinstein,et al. Signal transduction by a 5-HT2 receptor: a mechanistic hypothesis from molecular dynamics simulations of the three-dimensional model of the receptor complexed to ligands. , 1993, Journal of medicinal chemistry.
[35] J. Baldwin. The probable arrangement of the helices in G protein‐coupled receptors. , 1993, The EMBO journal.
[36] R. Lefkowitz,et al. A mutation-induced activated state of the beta 2-adrenergic receptor. Extending the ternary complex model. , 1993, The Journal of biological chemistry.
[37] G Vriend,et al. Modeling of transmembrane seven helix bundles. , 1993, Protein engineering.
[38] T. S. Kobilka,et al. Enhancement of membrane insertion and function in a type IIIb membrane protein following introduction of a cleavable signal peptide. , 1992, The Journal of biological chemistry.
[39] B. Kobilka,et al. Identification of intramolecular interactions in adrenergic receptors. , 1992, The Journal of biological chemistry.
[40] M. Caron,et al. Agonist-modulated palmitoylation of beta 2-adrenergic receptor in Sf9 cells. , 1992, The Journal of biological chemistry.
[41] J Hoflack,et al. Modeling of G-protein-coupled receptors: application to dopamine, adrenaline, serotonin, acetylcholine, and mammalian opsin receptors. , 1992, Journal of medicinal chemistry.
[42] T P Lybrand,et al. Three-dimensional structure for the beta 2 adrenergic receptor protein based on computer modeling studies. , 1992, Journal of molecular biology.
[43] C. Fraser,et al. In vitro mutagenesis and the search for structure-function relationships among G protein-coupled receptors. , 1992, The Biochemical journal.
[44] B. Kobilka,et al. Adrenergic receptors as models for G protein-coupled receptors. , 1992, Annual review of neuroscience.
[45] W. C. Probst,et al. Sequence alignment of the G-protein coupled receptor superfamily. , 1992, DNA and cell biology.
[46] M. Caron,et al. G-protein-coupled receptor genes as protooncogenes: constitutively activating mutation of the alpha 1B-adrenergic receptor enhances mitogenesis and tumorigenicity. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[47] B. Kobilka,et al. Construction and expression of chimeric receptors to understand the structure-function relationships in adrenergic receptors , 1991 .
[48] J. Wess,et al. Site‐directed mutagenesis of the m3 muscarinic receptor: identification of a series of threonine and tyrosine residues involved in agonist but not antagonist binding. , 1991, The EMBO journal.
[49] H. Khorana,et al. Mapping of the amino acids in membrane-embedded helices that interact with the retinal chromophore in bovine rhodopsin. , 1991, The Journal of biological chemistry.
[50] C. Strader,et al. Allele-specific activation of genetically engineered receptors. , 1991, The Journal of biological chemistry.
[51] C. Strader,et al. Biophysical and genetic analysis of the ligand-binding site of the beta-adrenoceptor. , 1991, Trends in pharmacological sciences.
[52] M. Caron,et al. Role of extracellular disulfide-bonded cysteines in the ligand binding function of the beta 2-adrenergic receptor. , 1990, Biochemistry.
[53] M. Caron,et al. Two distinct pathways for cAMP-mediated down-regulation of the beta 2-adrenergic receptor. Phosphorylation of the receptor and regulation of its mRNA level. , 1989, The Journal of biological chemistry.
[54] C. Fraser. Site-directed mutagenesis of beta-adrenergic receptors. Identification of conserved cysteine residues that independently affect ligand binding and receptor activation. , 1989, The Journal of biological chemistry.
[55] M. Caron,et al. Palmitoylation of the human beta 2-adrenergic receptor. Mutation of Cys341 in the carboxyl tail leads to an uncoupled nonpalmitoylated form of the receptor. , 1989, The Journal of biological chemistry.
[56] M. Caron,et al. The mammalian beta 2-adrenergic receptor: purification and characterization. , 1984, Biochemistry.
[57] C. D. Gelatt,et al. Optimization by Simulated Annealing , 1983, Science.
[58] A. Strosberg,et al. Evidence for essential disulfide bonds in beta1-adrenergic receptors of turkey erythrocyte membranes. Inactivation by dithiothreitol. , 1979, The Journal of biological chemistry.